Europe

A Review of the Trans-Atlantic Divide on Drug Prices Between the United States and the United Kingdom

Internal document seen by the Guardian shows low supplies for heart, cancer and anti-epilepsy drugs.

We should override patent protection on some medicines and change how R&D is funded.

Donald Trump wants the big US pharmaceutical companies to get its hands on our public services – and the Conservatives are conniving to help the sell-off.

Mr Corbyn is expected to confirm a pledge to force pharmaceutical companies to give up exclusive rights to produce drugs that they have developed themselves, in cases where the government decides that existing prices are too high.

The French ban on direct-to-consumer genetic testing is part of the country’s bioethics laws, which legislators are supposed to revise every seven years.

The state-run NHS has provided free at the point of use healthcare for more than 70 years.

The decision was reached as the two parties agreed to a patient access scheme to make the drug available to NHS patients.

Making the UK the best place in the World to research, develop and use the medicines of the future.

Vertex Pharmaceuticals Inc’s drugs for lung condition cystic fibrosis will now be available to patients across the UK after the company reached a pricing deal with Wales.

Are usage experience and outcome benefits from Person-Centered Therapeutic Innovations appropriately valued?

Health service in England would get £5.5bn more a year by 2023-24 than the £20.5bn promised by Conservatives.

An overview of pharmaceutical pricing and reimbursement in France.

It doesn’t matter who’s in the White House or what they ask for, there is no way in any deal that we will see drug prices rise or put the NHS anywhere near the table.

UK's NHS is already for sale – 18% of NHS funding now goes to private providers including Virgin Care.